Marieke den Brinker
Overview
Explore the profile of Marieke den Brinker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
253
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Desouter A, Keymeulen B, Van de Velde U, Van Dalem A, Lapauw B, De Block C, et al.
Diabetes Care
. 2025 Feb;
PMID: 39903487
Objective: Evidence for using continuous glucose monitoring (CGM) as an alternative to oral glucose tolerance tests (OGTTs) in presymptomatic type 1 diabetes is primarily cross-sectional. We used longitudinal data to...
2.
Van Eyck A, Ledeganck K, Vermeiren E, De Lamper A, Eysackers M, Mortier J, et al.
Eur J Pediatr
. 2023 Jun;
182(8):3743-3753.
PMID: 37289233
Hypomagnesemia in patients with type 1 diabetes (T1D) as well as in obesity has been related to insulin resistance in adults, but not yet in pediatric patients. In this observational...
3.
Dotremont H, France A, Heinrichs C, Tenoutasse S, Brachet C, Cools M, et al.
Front Endocrinol (Lausanne)
. 2023 Apr;
14:1113750.
PMID: 37008942
Objectives: To improve adult height in pubertal girls with a poor height prediction, treatment with growth hormone (GH) can be used in combination with a gonadotropin releasing hormone agonist (GnRHa),...
4.
Ledeganck K, Van Eyck A, Wouters K, Vermeiren E, De Winter B, Verhulst S, et al.
PLoS One
. 2023 Mar;
18(3):e0283716.
PMID: 36996194
An increased blood pressure is a known comorbidity of both type 1 diabetes (T1DM) and obesity in children. Increasing evidence suggests a subtle interplay between epidermal growth factor (EGF) and...
5.
De Ridder F, Charleer S, Jacobs S, Bolsens N, Ledeganck K, Van Aken S, et al.
Front Pediatr
. 2022 Oct;
10:991633.
PMID: 36275049
Objective: Real-time continuous glucose monitoring (RT-CGM) can improve metabolic control and quality of life (QoL), but long-term real-world data in children with type 1 diabetes (T1D) are scarce. Over a...
6.
Polle O, Delfosse A, Martin M, Louis J, Gies I, den Brinker M, et al.
Diabetes Care
. 2022 Aug;
45(10):2360-2368.
PMID: 35994729
Objective: To evaluate whether indexes of glycemic variability may overcome residual β-cell secretion estimates in the longitudinal evaluation of partial remission in a cohort of pediatric patients with new-onset type...
7.
Becue C, Ceuleers B, den Brinker M, Somers I, Ledeganck K, Dotremont H, et al.
Front Pediatr
. 2022 Aug;
10:902252.
PMID: 35911830
Background: Involving pediatric nephrological input in the clinical diagnostic work-up of children with short stature, gave rise to the hypothesis that the presence of an underlying renal tubular disorder in...
8.
Nimri R, Tirosh A, Muller I, Shtrit Y, Kraljevic I, Martin Alonso M, et al.
Diabetes Technol Ther
. 2022 Mar;
24(8):564-572.
PMID: 35325567
Artificial intelligence-based decision support systems (DSS) need to provide decisions that are not inferior to those given by experts in the field. Recommended insulin dose adjustments on the same individual...
9.
Ledeganck K, den Brinker M, Peeters E, Verschueren A, De Winter B, France A, et al.
Diabetes Res Clin Pract
. 2021 Jul;
178:108945.
PMID: 34245799
Aims: Micro-albuminuria is considered an early clinical sign of diabetes nephropathy, however, early decrease of glomerular filtration can be present years before the presence of microalbuminuria. In this study, we...
10.
Nimri R, Oron T, Muller I, Kraljevic I, Martin Alonso M, Keskinen P, et al.
J Diabetes Sci Technol
. 2020 Oct;
16(2):364-372.
PMID: 33100030
Aims: To compare insulin dose adjustments made by physicians to those made by an artificial intelligence-based decision support system, the Advisor Pro, in people with type 1 diabetes (T1D) using...